Literature DB >> 5816072

Maple syrup urine disease metabolites studies in cerebellum cultures.

D H Silberberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5816072     DOI: 10.1111/j.1471-4159.1969.tb05959.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  6 in total

1.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.

Authors:  P Jouvet; P Rustin; D L Taylor; J M Pocock; U Felderhoff-Mueser; N D Mazarakis; C Sarraf; U Joashi; M Kozma; K Greenwood; A D Edwards; H Mehmet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

Review 3.  Inborn errors of metabolism: clues to understanding human behavioral disorders.

Authors:  G S Omenn
Journal:  Behav Genet       Date:  1976-07       Impact factor: 2.805

4.  Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain.

Authors:  M S Patel
Journal:  Biochem J       Date:  1974-10       Impact factor: 3.857

5.  Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.

Authors:  S D Skaper; D P Molden; J E Seegmiller
Journal:  Biochem Genet       Date:  1976-08       Impact factor: 1.890

6.  Differential effects of 2-oxo acids on pyruvate utilization and fatty acid synthesis in rat brain.

Authors:  J B Clark; J M Land
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.